These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21488135)

  • 1. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.
    Thiele S; de Sanctis L; Werner R; Grötzinger J; Aydin C; Jüppner H; Bastepe M; Hiort O
    Hum Mutat; 2011 Jun; 32(6):653-60. PubMed ID: 21488135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
    Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
    de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas.
    Linglart A; Mahon MJ; Kerachian MA; Berlach DM; Hendy GN; Jüppner H; Bastepe M
    Endocrinology; 2006 May; 147(5):2253-62. PubMed ID: 16484323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
    Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
    J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency.
    Thiele S; Werner R; Ahrens W; Hoppe U; Marschke C; Staedt P; Hiort O
    J Clin Endocrinol Metab; 2007 May; 92(5):1764-8. PubMed ID: 17299070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different pattern of epigenetic changes of the GNAS gene locus in patients with pseudohypoparathyroidism type Ic confirm the heterogeneity of underlying pathomechanisms in this subgroup of pseudohypoparathyroidism and the demand for a new classification of GNAS-related disorders.
    Brix B; Werner R; Staedt P; Struve D; Hiort O; Thiele S
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1564-70. PubMed ID: 24878042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of two cases of pseudohypoparathyroidism (ia and ib) and molecular analysis of GNAS].
    Domínguez García A; Castaño González LA; Pérez-Nanclares G; Quinteiro González S; Caballero Fernández E
    An Pediatr (Barc); 2013 Nov; 79(5):319-24. PubMed ID: 23623851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
    Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
    Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.
    Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.
    De Sanctis L; Romagnolo D; Olivero M; Buzi F; Maghnie M; Scirè G; Crino A; Baroncelli GI; Salerno M; Di Maio S; Cappa M; Grosso S; Rigon F; Lala R; De Sanctis C; Dianzani I
    Pediatr Res; 2003 May; 53(5):749-55. PubMed ID: 12621129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.
    Long XD; Xiong J; Mo ZH; Dong CS; Jin P
    BMC Med Genet; 2018 Jul; 19(1):132. PubMed ID: 30060753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs{alpha} coding mutations and GNAS imprinting defects.
    Lecumberri B; Fernández-Rebollo E; Sentchordi L; Saavedra P; Bernal-Chico A; Pallardo LF; Bustos JM; Castaño L; de Santiago M; Hiort O; Pérez de Nanclares G; Bastepe M
    J Med Genet; 2010 Apr; 47(4):276-80. PubMed ID: 19858129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
    Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAS Spectrum of Disorders.
    Turan S; Bastepe M
    Curr Osteoporos Rep; 2015 Jun; 13(3):146-58. PubMed ID: 25851935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel GNAS mutation for pseudohypoparathyroidism in a Chinese family.
    Sun LH; Cui B; Zhao HY; Tao B; Wang WQ; Li XY; Ning G; Liu JM
    Endocrine; 2009 Aug; 36(1):25-9. PubMed ID: 19381884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new heterozygous mutation (D196N) in the Gs alpha gene as a cause for pseudohypoparathyroidism type IA in a boy who had gallstones.
    Winter J; Hiort O; Hermanns P; Thiele S; Pohlenz J
    J Pediatr Endocrinol Metab; 2011; 24(5-6):297-301. PubMed ID: 21823526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS.
    Swieringa F; Solari FA; Pagel O; Beck F; Huang J; Feijge MAH; Jurk K; Körver-Keularts IMLW; Mattheij NJA; Faber J; Pohlenz J; Russo A; Stumpel CTRM; Schrander DE; Zieger B; van der Meijden PEJ; Zahedi RP; Sickmann A; Heemskerk JWM
    Sci Rep; 2020 Jul; 10(1):11389. PubMed ID: 32647264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.